Zobrazeno 1 - 10
of 119
pro vyhledávání: '"C M, Clark"'
Autor:
Matthew L. Broadhead, Jonathan C. M. Clark, Damian E. Myers, Crispin R. Dass, Peter F. M. Choong
Publikováno v:
Sarcoma, Vol 2011 (2011)
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60%–70%, with no significant improvements
Externí odkaz:
https://doaj.org/article/c410c31dddd04a91b28d36d0f11464a4
Publikováno v:
The Journal of Laryngology & Otology. 131:298-302
Background:Histopathological anomalies of inner-ear structures in individuals with Down syndrome have been well documented; however, few studies have examined the radiological features.Methods:A retrospective study was conducted of temporal bone comp
Autor:
Stephen T Byrne, Renate M Kalnins, Augusto Gonzalvo, Myron A. Rogers, Jonathan C. M. Clark, Bryden Dawes
Publikováno v:
Journal of Clinical Neuroscience. 21:1990-1993
We report a 44-year-old with progressive quadriparesis due to a dumbbell malignant peripheral nerve sheath tumour (MPNST) of the second cervical nerve, 17 years after whole brain radiotherapy for a pineal germinoma. To our knowledge this is the first
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 45
Angiosarcomas (ASs) are rare malignant vascular tumours, which only occasionally occur in the spine. The prognosis is generally poor due to rarity of the condition as well as lack of data of treatment options. We present the case of a 75-year old man
Autor:
John B. Furness, James F. Patrick, Graeme M. Clark, Tina Cardamone, Kathryn Spiers, Jonathan C. M. Clark
Publikováno v:
Cochlear implants international. 17(3)
The aim of this study was to analyse the tissue surrounding the University of Melbourne's (UOMs) multi-channel cochlear implant electrode array and cochlear limited replacements, after long-term implantations. In particular, it aimed to identify the
Autor:
David Thomas, Han-Soo Kim, Crispin R. Dass, Toru Akiyama, Stuart J. Galloway, Andreas Evdokiou, Agatha Labrinidis, Peter F. M. Choong, Jonathan C. M. Clark
Publikováno v:
Cancer. 117:3517-3528
BACKGROUND: Targeted therapy in osteosarcoma (OS) is needed to improve patient outcomes. Human RECK may have a role because it inhibits cancer invasion and regulates angiogenesis. This study aimed to characterize RECK expression in human OS, to exami
Autor:
Jonathan C. M. Clark, Damian E. Myers, Crispin R. Dass, Peter F. M. Choong, Matthew L. Broadhead
Publikováno v:
Sarcoma
Sarcoma, Vol 2011 (2011)
Sarcoma, Vol 2011 (2011)
Osteosarcoma is the most common primary malignancy of bone. It arises in bone during periods of rapid growth and primarily affects adolescents and young adults. The 5-year survival rate for osteosarcoma is 60%–70%, with no significant improvements
Publikováno v:
The Journal of Bone and Joint Surgery. British volume. :999-1005
Internal hemipelvectomy is a standard treatment for malignant tumours of the pelvis. Reconstruction using a non-vascularised fibular graft is relatively straightforward compared to other techniques. We describe the surgical and functional outcomes fo
Publikováno v:
ANZ Journal of Surgery. 80:531-536
Microarray enables the study of thousands of genes simultaneously. While still in its infancy as a technique and with a number of barriers to be overcome, microarray is allowing scientists to thoroughly examine the molecular pathways of cancer pathog
Publikováno v:
Expert Review of Anticancer Therapy. 10:477-480
Gene therapy for osteosarcoma is gaining additional momentum with the introduction of delivery vehicles such as hydrogels [52] and modified adenoviral vectors. With safer gene-delivery vehicles being produced, nucleic acid-based therapeutic construct